Human ADAMTS4 MAb (Clone 416610)
R&D Systems, part of Bio-Techne | Catalog # MAB4307
Key Product Details
Species Reactivity
Applications
Label
Antibody Source
Product Specifications
Immunogen
Phe213-Cys685
Accession # O75173
Specificity
Clonality
Host
Isotype
Scientific Data Images for Human ADAMTS4 MAb (Clone 416610)
ADAMTS4 in SH‑SY5Y Human Cell Line.
ADAMTS4 was detected in immersion fixed SH-SY5Y human neuroblastoma cell line using Mouse Anti-Human ADAMTS4 Monoclonal Antibody (Catalog # MAB4307) at 8 µg/mL for 3 hours at room temperature. Cells were stained using the NorthernLights™ 557-conjugated Anti-Mouse IgG Secondary Antibody (red; Catalog # NL007) and counterstained with DAPI (blue). Specific staining was localized to cytoplasm. View our protocol for Fluorescent ICC Staining of Cells on Coverslips.Applications for Human ADAMTS4 MAb (Clone 416610)
Immunocytochemistry
Sample: Immersion fixed SH-SY5Y human neuroblastoma cell line
Immunoprecipitation
Sample: Conditioned cell culture medium spiked with Recombinant Human ADAMTS4 (Catalog # 4307-AD), see our available Western blot detection antibodies
Western Blot
Sample: Recombinant Human ADAMTS4 (Catalog # 4307-AD) under non-reducing conditions only
Formulation, Preparation, and Storage
Purification
Reconstitution
Formulation
Shipping
Stability & Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: ADAMTS4
ADAMTS4 (a disintegrin and metalloproteinase with thrombospondin motifs 4), also known as aggrecanase-1, is a member of the family of secreted zinc proteases with a multi-domain structure (1‑3). The protein precursors consist of a signal peptide and the following domains: pro, catalytic, disintegrin-like, TS type 1 motif, cysteine-rich, and spacer. It is the only ADAMTS identified that has one TS type I motif. It is an active protease effectively cleaving alpha-2-macroglobulin and aggrecan at multiple sites, and is inhibited by TIMP-3 with inhibition constants in subnanomolar range (4‑6). It receives great attention due to the elevation in its mRNA level after treatment with Interleukin-1 (7). However, in a mouse model of osteoarthritis, ADAMTS4 knock-out mice did not exhibit any significant protective effect (8). ADAMTS4 consists of a signal peptide (aa 1 to 51), a pro domain (aa 52 to 212) and a mature chain (aa 213 to 837) containing the following domains: catalytic (aa 218 to 425), disintegrin (aa 437 to 519), TSP type-1 (aa 520 to 575), Cys-rich (aa 577 to 685) and spacer (aa 686 to 837). The amino acid sequence of rhADAMTS4 is 100%, 97% and 94% identical to that of chimpanzee, dog, and mouse/rat/bovine.
References
- Totorella, M. D. et al. (1999) Science 284:1664.
- Porter, S. et al. (2005) Biochem. J. 386:15.
- Nagase, H. and M. Kashiwagi (2003) Arthritis Res. Ther. 5:94.
- Tortorella, M. D. et al. (2004) J. Biol. Chem. 279:17554.
- Struglics, A. et al. (2006) Osteoarthritis Cartilage. 14:101.
- Kashiwagi, M. et al. (2001) J. Biol. Chem. 276:12501.
- Pratta, M. A. et al. (2003) Arthritis Reum. 48:119.
- Glasson, S. S. et al. (2004) Arthritis Reum. 50:2547.
Long Name
Alternate Names
Gene Symbol
UniProt
Additional ADAMTS4 Products
Product Documents for Human ADAMTS4 MAb (Clone 416610)
Product Specific Notices for Human ADAMTS4 MAb (Clone 416610)
For research use only